AlphaYouMS
Schedule 13D filing
Moringa Sponsor, LP disclosed a 17.7% stake in Silexion Therapeutics Corp (SLXN)
Moringa Sponsor, LP reported owning 17.7% of Silexion Therapeutics Corp (SLXN) (1,954,056 shares) in a Schedule 13D filed Sep 28, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 28, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.